Vyriad, Inc.

About Vyriad, Inc.

Vyriad is a company focused on engineering targeted, efficient, and stable virus platforms to deliver durable in vivo gene therapies, genome editing, and oncolytic virotherapies to patients. Founded by scientists at Mayo Clinic and based in Rochester, Minnesota, Vyriad collaborates with leading medical institutions and pharmaceutical companies to advance the development of targeted genetic therapies worldwide.

Products & Services

In Vivo Platforms:Virus platforms designed for in vivo CAR-T therapies and gene editing applications.

Oncolytic Virus Platforms:Includes VSV (Vesicular Stomatitis Virus) and Measles-based platforms for oncolytic virotherapies targeting cancer cells.

Clinical Programs:Clinical trials involving oncolytic viruses as monotherapies or in combination with immuno-oncology drugs for multiple cancer indications.

Specialties

In Vivo Gene Therapy Gene Editing Oncolytic Virotherapy Viral Vector Engineering Preclinical Development Clinical Expertise Manufacturing of Viral Therapies

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 25000000 MR: - FA: $25 million FAN: 25000000	D: 2025-12-23 FD: 2025-12-23	2 investors

Series B Latest

2025-12-23

$25.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

H

Harry N. Hoffman

Emeritus Chief Investment Officer and Treasurer Mayo Clinic Treasury Services

S

Stephen J. Russell

Co-Founder and Chief Executive Officer

E

Edwin Kania

Chairman of the Board, Vyriad, Inc. Managing Partner, FarField Partners

J

James Hampton

Professor of Biology

H

Harry Stine

CEO of Stine Seed Company

K

Kah-Whye Peng

Co-Founder and Chief Technical Officer

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

Vyriad, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised